Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-30

Clinical Trial Update: A Noval Tau Tracer in Young Onset Dementia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a novel tau tracer for young onset dementia, currently in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Alzheimer's Disease, Vascular Dementia | Phase 1, Phase 2 | Status: UNKNOWN